Skip to content

Our Technology
Our Business model
Newsroom
- News & Press Releases
- Pressroom
Contact

Our Technology
Our Business model
Newsroom
- News & Press Releases
- Pressroom
Contact

September 25, 2023

Financing for the clinical evaluation of MaMa-K was secured

Financing for the clinical evaluation of MaMa-K was secured and approved at the Extraordinary General Meeting in Oslo.

PrevPreviousNew CEO and chairman of Kongsberg Beam Technology AS

NextNew visiting adress – Close to the new proton therapy facilityNext

About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.

Follow Us

© 2026 Kongsberg Beam Technology | All rights reserved